PROGNOSTIC METHOD FOR CHECKING EFFICACY OF MICRO RNA-122 INHIBITORS IN HCV+ PATIENTS

The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122 inhibitor. The invention also provides for prognostic methods for determining the suitability of treatment of hepatitis C infection with an anti-...

Full description

Saved in:
Bibliographic Details
Main Authors PETRI, ANDREAS, KAUPPINEN, SAKARI, LINDOW, MORTEN, HAGEDORN, PETER
Format Patent
LanguageEnglish
French
German
Published 26.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122 inhibitor. The invention also provides for prognostic methods for determining the suitability of treatment of hepatitis C infection with an anti-HCV agent such as a miR-122 inhibitor.
AbstractList The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122 inhibitor. The invention also provides for prognostic methods for determining the suitability of treatment of hepatitis C infection with an anti-HCV agent such as a miR-122 inhibitor.
Author KAUPPINEN, SAKARI
PETRI, ANDREAS
LINDOW, MORTEN
HAGEDORN, PETER
Author_xml – fullname: PETRI, ANDREAS
– fullname: KAUPPINEN, SAKARI
– fullname: LINDOW, MORTEN
– fullname: HAGEDORN, PETER
BookMark eNqNyr8KwjAQgPEMOvjvHW6Xgq3U4tieSXNIcyU9BKdSJE6SFur7o4MP4PT9hm-tFnGMYaWk9Vw77oQQGi2WL2DYA1qNV3I1aGMIS7wDG2gIPYN3ZZJmGZCzVJGw774Ei7c9tKWQdtJt1fI5vOaw-3WjwGhBm4Rp7MM8DY8Qw7vXbVYUp_x8qNLjH8sHvJcw6Q
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate PROGNOSTISCHES VERFAHREN ZUR BEURTEILUNG DER ARZNEIMITTELWIRKSAMKEIT VON MICRO RNA-122 INHIBITOREN IN HCV+ PATIENTEN
PROCÉDÉ PROGNOSTIQUE D'ÉVALUATION DE L'EFFICACITÉ D'INHIBITEURS MICRO RNA-122 EN HCV+ PATIENTS
ExternalDocumentID EP2776590B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2776590B13
IEDL.DBID EVB
IngestDate Fri Jul 19 16:01:05 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2776590B13
Notes Application Number: EP20120784565
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161026&DB=EPODOC&CC=EP&NR=2776590B1
ParticipantIDs epo_espacenet_EP2776590B1
PublicationCentury 2000
PublicationDate 20161026
PublicationDateYYYYMMDD 2016-10-26
PublicationDate_xml – month: 10
  year: 2016
  text: 20161026
  day: 26
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies ROCHE INNOVATION CENTER COPENHAGEN A/S
RelatedCompanies_xml – name: ROCHE INNOVATION CENTER COPENHAGEN A/S
Score 3.0488937
Snippet The present invention relates to the treatment of subjects infected with HCV which have been identified as likely responders to HCV therapy with a miR-122...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
Title PROGNOSTIC METHOD FOR CHECKING EFFICACY OF MICRO RNA-122 INHIBITORS IN HCV+ PATIENTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161026&DB=EPODOC&locale=&CC=EP&NR=2776590B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La4NAEB5C-ry1aUvTF3soXorUx8boIZS4arQQV8w2pKegRiEXExpL_35HSdJe2tswC8PuwDy-3ZlZgMeemphmXixkamZUpnqiyZaZKnJmaEpRoNNUk7pReBwa_ht9nfVmLVjuemGaOaFfzXBEtKgM7b1q_PX65xLLaWorN8_pElmrF08MHGmLjjF9QUwhOfbAjbjDmcQYUlIYD7R-3-hZio1A6aDOousx--7UrptS1r8jincGhxEKK6tzaOVlB07Y7uO1DhyPt-_dHThqCjSzDTK3Rri5ABHFfBTyiQgYGbvC5w5BKEeY7zLE4iOCqWfAhuydcI-gkmNO4nAoq5pGgtAP7EDweIIk8dn0iURDEbihmFwC8VzBfBk3Ot8rZe5G-yPpV9AuV2V-DYSmmrUocj1FFEBpsbDSPgIa1UoUJStSM-lC908xN_-s3cJprd3aaWvGHbSrj8_8HqNxlT40evwGHI-Gzg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ409VFvWjXW5x4MF0MESikcGlMWKGhhCV0bPTVAIemFNhbj33cgbfWit8lsMtmdZB7f7swswH1PjnU9y-eiqqeqqHZjRTT0RBJTTZHyHJ2mHFeNwn6gua_q81vvrQGLbS9MPSf0qx6OiBaVor2Xtb9e_VxiWXVt5foxWSBr-eTwgSVs0DGmL4gpBMsc2CGzGBUoRUoIooHS72s9QzIRKO31q-G8VeY0NaumlNXviOIcw36IworyBBpZ0YYW3X681oZDf_Pe3YaDukAzXSNzY4TrU-BhxEYBm3CPEt_mLrMIQjlCXZsiFh8RTD09OqTvhDkElRwxEgVDUVYU4gWuZ3qcRRMkiUunDyQccs8O-OQMiGNz6oq40dlOKTM73B2pew7NYllkF0DURDHmedZNEAWoaj43kj4CGtmIJSnNEz3uQOdPMZf_rN1By-X-eDb2gpcrOKo0XTlwRbuGZvnxmd1gZC6T21qn35Nmibs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PROGNOSTIC+METHOD+FOR+CHECKING+EFFICACY+OF+MICRO+RNA-122+INHIBITORS+IN+HCV%2B+PATIENTS&rft.inventor=PETRI%2C+ANDREAS&rft.inventor=KAUPPINEN%2C+SAKARI&rft.inventor=LINDOW%2C+MORTEN&rft.inventor=HAGEDORN%2C+PETER&rft.date=2016-10-26&rft.externalDBID=B1&rft.externalDocID=EP2776590B1